UK Market Access
Our work is focussed on effective adoption and spread of HealthTech innovation within the NHS.
At the heart of this, lies the operationalisation of value-based procurement. We recognise that procurement is not merely a transactional process but a strategic driver of value in healthcare. By embracing this approach, we are poised to build on our progress and ensure that every procurement decision contributes to improved patient outcomes, efficient resource allocation, and sustainable healthcare delivery.
The NHS England Commercial Strategic Framework is fundamental to healthcare procurement, and whilst it represents a powerful tool for driving efficiency and effectiveness, we are acutely aware of the challenges that may arise. Our commitment is to understand, address, and manage these challenges proactively, ensuring that the framework continues to serve as a catalyst for positive change in the NHS procurement landscape.
The National Institute for Health and Care Excellence (NICE) plays a pivotal role in shaping healthcare decisions. We are dedicated to ensuring that changes to guidance programmes, including late-stage assessments, are not only relevant but also fit for purpose. Our collaboration with NICE reflects our commitment to evidence-based decision-making and ensuring that patients receive the highest quality care based on the latest guidelines.
We are actively engaging with the Department of Health and Social Care (DHSC)'s MedTech Strategy, which provides important recognition of HealthTech's transformative potential. We are working to ensure that its policy decisions align with the goals of advancing patient care, fostering innovation, and driving economic growth.